Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 57, 2022 - Issue 2
Submit an article Journal homepage
352
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5‐aminosalicylate acid: a single-center, observational study

Yuri Tsujiia Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
,
Tsutomu Nishidaa Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4037-9003
ORCID Icon,
Naoto Osugia Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
,
Yoshifumi Fujiia Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
,
Aya Sugimotoa Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
,
Dai Nakamatsua Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
,
Kaori Mukaia Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
,
Kengo Matsumotoa Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
,
Shiro Hayashib Department of Gastroenterology and Internal Medicine, Hayashi Clinic, Suita, Japan
,
Masashi Yamamotoa Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
&
Sachiko Nakajimaa Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Japan
 show all
Pages 190-196 | Received 20 Aug 2021, Accepted 18 Oct 2021, Published online: 09 Nov 2021

References

  • Loftus EV Jr., Kane SV, Bjorkman D. Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2004;19(2):179–189.
  • Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021;56(6):489–526.
  • Goldstein F, DiMarino AJ Jr. Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease. J Clin Gastroenterol. 2000;31(1):60–62.
  • Shimodate Y, Takanashi K, Waga E, et al. Exacerbation of bloody diarrhea as a side effect of mesalamine treatment of active ulcerative colitis. Case Rep Gastroenterol. 2011;5(1):159–165.
  • Jaup BH. Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl). Dtsch Med Wochenschr. 1978;103(30):1211–1213.
  • Griffiths ID, Kane SP. Sulphasalazine-induced lupus syndrome in ulcerative colitis. Br Med J. 1977;2(6096):1188–1189.
  • Clementz GL, Dolin BJ. Sulfasalazine-induced lupus erythematosus. Am J Med. 1988;84(3 Pt 1):535–538.
  • Carr-Locke DL. Sulfasalazine-induced lupus syndrome in a patient with Crohn's disease. Am J Gastroenterol. 1982;77(9):614–616.
  • Kirkpatrick AW, Bookman AA, Habal F. Lupus-like syndrome caused by 5-aminosalicylic acid in patients with inflammatory bowel disease. Can J Gastroenterol. 1999;13(2):159–162.
  • Kim KH, Kim TN, Jang BI. A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis. Korean J Gastroenterol. 2007;50(6):379–383.
  • Mizuno S, Ono K, Mikami Y, et al. 5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis. Intest Res. 2020;18(1):69–78.
  • Hiraoka S, Fujiwara A, Toyokawa T, et al. Multicenter survey on mesalamine intolerance in patients with ulcerative colitis. J Gastroenterol Hepatol. 2021;36(1):137–143.
  • Matsumoto S, Mashima H. Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease. Sci Rep. 2020;10(1):22176.
  • Timsit MA, Anglicheau D, Lioté F, et al. Mesalazine-induced lupus. Rev Rhum Engl Ed. 1997;64(10):586–588.
  • Ministry of Health, Labour and Welfare Grant-in-Aid for Scientific Research on Intractable Diseases. Research on intractable inflammatory bowel disorders; 2021; [cited 2021 Jun 15]. Available from: http://www.ibdjapan.org/pdf/doc01.pdf
  • World Health Organization. Drug and Therapeutics Committee Training Course. Session 4. Assessing and managing medicine safety; 2021 [cited 2021 Jul 13]. Available from: https://www.who.int/medicines/technical_briefing/tbs/04-PG_Dug-Safety_final-08.pdf?ua=1
  • National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE); 2021 [cited 2021 Sep 24]. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40
  • Ito H, Iida M, Matsumoto T, et al. Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study. Inflamm Bowel Dis. 2010;16(9):1567–1574.
  • Hiwatashi N, Suzuki Y, Mitsuyama K, et al. Clinical trial: effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study. J Gastroenterol. 2011;46(1):46–56.
  • Katsanos KH, Voulgari PV, Tsianos EV. Inflammatory bowel disease and lupus: a systematic review of the literature. J Crohns Colitis. 2012;6(7):735–742.
  • Takikawa H. Recent status of drug-induced liver injury. Hepatol Res. 2009;39(1):1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.